I don't know if anyone else has been listening to the debate about Glaxo Smith Kline's historical practice for which they have been fined. John Humphries put on his most outraged voice it on the radio this morning saying "why don't the public know about this".
This is of interest to me because I take a lay woman's interest in all the statin trials and the way their data is presented, the cholesterol sceptics would say much better than it actually is.
I hope this debate runs on.
I would encourage anybody who has an adverse drug reaction from a statin to report it to the MHRA yellow card scheme, the more data from patients the better.